ASH 2024: Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care - Episode 16
Myelofibrosis at ASH 2024: Key Updates and Emerging Therapies
Panelists discuss noteworthy updates in myelofibrosis (MF) from ASH 2024, share their views on the future of MF treatment, offer clinical pearls for community oncologists, and highlight emerging pathways and targets they are excited about for MF management.
Video content above is prompted by the following:
Dr Kuykendall to faculty: What outstanding updates in MF from ASH 2024 are noteworthy?
Dr Kuykendall to faculty: What do you see for the future of MF treatment?
- What clinical pearls can you leave for community oncologists?
- What emerging pathways/targets are you excited about for the management of MF?
Related Content:
